Validation of exacerbation history grading by GOLD for predicting future COPD outcomes

<bold>Background:</bold> Individuals with COPD often experience exacerbations (ECOPD). For over a decade, high ECOPD risk is stratified according to a history of ≥2 moderate ECOPD and/or ≥1 severe ECOPD in <12 months. To date, these cutoffs lack validation. <bold>Objectives:</bold> To validate the ECOPD history frequency cutoff values suggested by GOLD, and to explore potential other cutoff strategies to predict ECOPD and all-cause mortality. <bold>Methods:</bold> Data from patients with COPD of the German COSYCONET cohort study were analyzed. Risk of ECOPD, hospitalizations and all-cause mortality during 4.5 years were assessed using binomial logistic regressions, and area under the ROC curves (AUC-ROC) with 95% confidence intervals (CI). <bold>Results:</bold> 2,291 patients with COPD GOLD 1-4 (mean age 65±8 years, 61% male, FEV1 53±19% predicted) were included. ECOPD history cutoff points by GOLD showed an AUC of 0.63 (95% CI 0.60-0.65) and 0.62 (95% CI 0.58-0.66) to predict ECOPD and hospitalizations, respectively. One previous ECOPD <12 months (AUC 0.66, 95% CI 0.64-0.69) more accurately predicted ECOPD and hospitalizations, and in line with GOLD, one previous hospitalization <12 months (AUC 0.63, 95% CI 0.60-0.67) predicted ECOPD and hospitalizations. The 4-year mortality rate was 9.6%. Patients with ≥3 previous ECOPD or ≥1 previous hospitalizations in <12 months were 2.18 (95% CI 1.27-3.72) and 1.57 (95% CI 1.29-1.91) times more likely to die, respectively. <bold>Conclusions:</bold> This study highlights the limited predictive performance of the current COPD risk assessment by GOLD. Novel cutoffs were suggested, categorizing patients as non-exacerbators or high-risk exacerbators based on a history of ≥1 ECOPD and/or ≥1 hospitalization <12 months.

Authors

Institutions

Publication Details

Published
2024-09-14
DOI
https://doi.org/10.1183/13993003.congress-2024.oa4647
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Validation of exacerbation history grading by GOLD for predicting future COPD outcomes

Sarah Houben‐Wilke, Frits M.E. Franssen, Peter J. Alter, Martijn A. Spruit et al.
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Validation of exacerbation history grading by GOLD for predicting future COPD outcomes

Sarah Houben‐Wilke, Frits M.E. Franssen, Peter J. Alter, Martijn A. Spruit, Rudolf A. Jörres, Klaus F. Rabe, Kiki Waeijen-Smit, Robert Bals, Tim Speicher, Daphne Peerlings, Claus Franz Vogelmeier, Tobias Welte, Henrik Watz, Sami O. Simons
article en

Abstract

<bold>Background:</bold> Individuals with COPD often experience exacerbations (ECOPD). For over a decade, high ECOPD risk is stratified according to a history of ≥2 moderate ECOPD and/or ≥1 severe ECOPD in <12 months. To date, these cutoffs lack validation. <bold>Objectives:</bold> To validate the ECOPD history frequency cutoff values suggested by GOLD, and to explore potential other cutoff strategies to predict ECOPD and all-cause mortality. <bold>Methods:</bold> Data from patients with COPD of the German COSYCONET cohort study were analyzed. Risk of ECOPD, hospitalizations and all-cause mortality during 4.5 years were assessed using binomial logistic regressions, and area under the ROC curves (AUC-ROC) with 95% confidence intervals (CI). <bold>Results:</bold> 2,291 patients with COPD GOLD 1-4 (mean age 65±8 years, 61% male, FEV1 53±19% predicted) were included. ECOPD history cutoff points by GOLD showed an AUC of 0.63 (95% CI 0.60-0.65) and 0.62 (95% CI 0.58-0.66) to predict ECOPD and hospitalizations, respectively. One previous ECOPD <12 months (AUC 0.66, 95% CI 0.64-0.69) more accurately predicted ECOPD and hospitalizations, and in line with GOLD, one previous hospitalization <12 months (AUC 0.63, 95% CI 0.60-0.67) predicted ECOPD and hospitalizations. The 4-year mortality rate was 9.6%. Patients with ≥3 previous ECOPD or ≥1 previous hospitalizations in <12 months were 2.18 (95% CI 1.27-3.72) and 1.57 (95% CI 1.29-1.91) times more likely to die, respectively. <bold>Conclusions:</bold> This study highlights the limited predictive performance of the current COPD risk assessment by GOLD. Novel cutoffs were suggested, categorizing patients as non-exacerbators or high-risk exacerbators based on a history of ≥1 ECOPD and/or ≥1 hospitalization <12 months.

Philipps University of Marburg (DE), Maastricht University Medical Centre (NL), Maastricht University (NL), Medizinische Hochschule Hannover (DE), München Klinik (DE), German Center for Lung Research (DE), Ciro (NL), LungenClinic Grosshansdorf (DE), Saarland University (DE)
Openalex Percentile: Top 63%
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.